213 related articles for article (PubMed ID: 15451756)
21. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
Della Bella P
Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
[No Abstract] [Full Text] [Related]
22. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
24. Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient.
Kostopoulou A; Sbarouni E; Livanis EG; Theodorakis GN; Kremastinos D
Europace; 2004 May; 6(3):205-8. PubMed ID: 15121071
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
[TBL] [Abstract][Full Text] [Related]
26. [Implantable cardioventer defibrillator in the treatment of malignant ventricular arrhythmias and its short-term follow-up].
Liu QM; Zhang Y; Zhou SH
Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):179-80. PubMed ID: 12575357
[No Abstract] [Full Text] [Related]
27. [Guidelines for cardioverter defibrillator implantation].
Andrade JC; Avila Neto V; Braile DM; Brofman PR; Costa AR; Costa R; Galvão Filho SS; Gauch PR; Lucchese FA; Martinelli Filho M; Medeiros PT; Mateos JC; Pimenta J; Takeda RT
Arq Bras Cardiol; 2000 May; 74(5):481-2. PubMed ID: 10951840
[No Abstract] [Full Text] [Related]
28. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
Zareba W
Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
[No Abstract] [Full Text] [Related]
29. Learning more about indications for implantable cardioverter-defibrillators.
Myerburg RJ; Castellanos A
J Am Coll Cardiol; 1999 Oct; 34(4):1096-8. PubMed ID: 10520796
[No Abstract] [Full Text] [Related]
30. Cost-effectiveness of the implantable cardioverter defibrillator?
Hlatky MA; Bigger T
Lancet; 2001 Jun; 357(9271):1817-8. PubMed ID: 11410185
[No Abstract] [Full Text] [Related]
31. Effectiveness of early implantation of cardioverter defibrillator for postoperative ventricular tachyarrhythmia.
Bolad I; MacLellan C; Karanam S; Parrella F; Michaud G; D'Agostino R; Shahian D; John R; Martin D
Am J Cardiol; 2004 Aug; 94(3):376-8. PubMed ID: 15276111
[TBL] [Abstract][Full Text] [Related]
32. Implantable cardioverter-defibrillators.
Kutalek SP; Dreifus LS
Adv Intern Med; 1993; 38():421-38. PubMed ID: 8438649
[No Abstract] [Full Text] [Related]
33. Implantable cardioverter/defibrillators (ICDs).
Med Lett Drugs Ther; 1994 Sep; 36(932):86-8. PubMed ID: 8084305
[No Abstract] [Full Text] [Related]
34. Implantable cardioverter/defibrillator therapy: the meaning of terms.
Smith ER
Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
[No Abstract] [Full Text] [Related]
35. Cost-effectiveness of implantable cardioverter-defibrillators.
Boriani G; Biffi M; Martignani C; Gallina M; Branzi A
Eur Heart J; 2001 Jun; 22(12):990-6. PubMed ID: 11428834
[No Abstract] [Full Text] [Related]
36. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:
Sweeney MO
Pacing Clin Electrophysiol; 2004 Sep; 27(9):1292-305. PubMed ID: 15461721
[No Abstract] [Full Text] [Related]
37. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
Naccarelli GV
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
[No Abstract] [Full Text] [Related]
38. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
39. [Automatic implanted cardioverter-defibrillators (AICD)].
Giec L; Trusz-Gluza M
Kardiol Pol; 1992 Dec; 37(12):405-9. PubMed ID: 1293351
[No Abstract] [Full Text] [Related]
40. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
